CN105403648A - Method for detecting illegally-added fluoxetine in product - Google Patents
Method for detecting illegally-added fluoxetine in product Download PDFInfo
- Publication number
- CN105403648A CN105403648A CN201510784041.9A CN201510784041A CN105403648A CN 105403648 A CN105403648 A CN 105403648A CN 201510784041 A CN201510784041 A CN 201510784041A CN 105403648 A CN105403648 A CN 105403648A
- Authority
- CN
- China
- Prior art keywords
- peak
- product
- fluoxetine
- sample
- prozac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
- G01N2030/8845—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds involving halogenated organic compounds
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
The invention discloses a method for detecting illegally-added fluoxetine in a product. The method comprises the following steps: carrying out primary screening and content determination by adopting a high performance liquid chromatography; and by adopting a high performance liquid chromatography-mass spectrograph, carrying out structure confirmation through comparing retention time of a sample peak and a comparison product peak, and quasimolecule ion peak and secondary mass spectrum fragment information. The method provided by the invention has strong specificity, high sensitivity and accuracy, good stability and strong practicability, and provides powerful technical supports for detection standards of the illegally-added fluoxetine in national designated products.
Description
Technical field
The present invention relates to Chinese medicine, health food and food quality detection field, be specifically related to a kind of illegal method of adding Prozac in testing product.
Background technology
In Chinese medicine and health food and food, illegal fat-reducing class chemicals situation of adding is serious in recent years, lawless person is for pursuing economic interests, reach the positive effect of quick weight-lossing, western medicine composition is added in Chinese medicine, health food and food, addition reaches or usually close to western medicine dosage, user takes when ignorant, and meeting high risks is healthy.When day-to-day supervision is checked, common detecting illegally adds sibutramine (clenbuterol hydrochloride), phenolphthalein, food Bureau of Drugs Supervision of country successively promulgates that drug inspection supplements the method for inspection and Interventions Requested approved document 2006004,2012005 and food medicine prison and does [2010] No. 114 file attachment 2 perhaps for this reason, for illegally adding the supervision and inspection of sibutramine and two kinds of derivants, phenolphthalein, caffeine, frusemide, fenfluramine, ephedrine totally 8 kinds of compositions.But lawless person is for escaping supervision, adding means and kind are constantly updated, change, carry out high-tech fraud for standard.Inventor detects recently in fat-reducing class sample and with the addition of a kind of new chemical medicine---Prozac.
Prozac, having another name called Prozac (fluoxetine, trade name is Prozac), is a kind of Oral antidepressant medicine, is used for the treatment of depression and its adjoint anxiety, and treatment obsession and disease of eating too much at one meal, thus have antiobesity action.It is antipsychotics, will produce great damage to the spirit of user.There is no at present and add Prozac qualitatively screening and method for quantitatively determining for illegal in product.Therefore set up illegal detection method of adding Prozac in product to be very important.
Summary of the invention
The present invention is intended to the deficiency overcoming existing detection method, provides a kind of illegal method of adding Prozac in testing product, can detect Prozac accurately and rapidly.
The present invention considers that high performance liquid chromatograph (outfit diode array detector) is the conventional detection apparatus of domestic testing laboratory, therefore high performance liquid chromatography preliminary screening and content assaying method is established, meet the actual conditions of domestic medicine testing agency, be conducive to effective enforcement of supervision and inspection.For primary dcreening operation positive, adopt Liquid Chromatography/Mass Spectrometry structural identification.The testing agency being equipped with LC-MS instrument also can directly use LC-MS method to screen and confirmation.
In order to achieve the above object, technical scheme provided by the invention is:
In described testing product, illegal interpolation Prozac prescreening method is extracted through methyl alcohol by sample, and gradient elution is separated and diode array detector (DAD) detects.The comparing of middle chromatographic peak and extract with fluoxetine product chromatographic peak retention time and spectrum behavior per sample, tentatively judge whether to detect Prozac.
In described testing product, illegal confirmation method of adding Prozac is extracted through methyl alcohol the positive of primary dcreening operation, and UPLC gradient elution is separated, Mass Spectrometer Method; By the retention time at comparative sample peak and reference substance peak, quasi-molecular ion peak and second order ms patch information, in confirmation sample, whether illegally add Prozac.
In described testing product, the illegal content assaying method adding Prozac is the high-efficient liquid phase chromatogram condition adopting prescreening method, calculates content by external standard method.
Specifically comprise the steps:
(1) by ultrasonic for sample methyl alcohol extraction;
(2) need testing solution after extraction is injected high performance liquid chromatograph, gradient elution is separated and diode array detector (DAD) detects; In this step, described liquid chromatograph is for wearing peace U3000 high performance liquid chromatograph;
(3) the positive need testing solution injection liquid matter combined instrument after extraction is carried out ultra high efficiency liquid phase gradient elution to be separated and Mass Spectrometer Method; In this step, described LC-MS instrument is ABSciexTripleTOF5600+ high-resolution mass spectrometer, Shimadzu NexeraUHPLCLC-30A high performance liquid chromatograph.
Chromatographic condition in step (2) is: take octadecylsilane chemically bonded silica as filling agent; With methanol-acetonitrile-0.8% triethylamine solution (with phosphoric acid adjust pH to 5.8) (5:35:60) for mobile phase; Determined wavelength is 226nm, and scanning wavelength scope is 190 ~ 400nm, flow velocity 1.0mL/min, sample size 5 μ L.
Chromatographic condition in step (3) is: with the 10mmol/L ammonium acetate solution containing 0.1% glacial acetic acid for mobile phase A, take methyl alcohol as Mobile phase B, gradient elution program 0 ~ 1min, 20%B; 1 ~ 6min, 20% ~ 80%B; 6 ~ 8min, 80%B; Determined wavelength is 226nm, flow velocity 0.3mL/min, sample size 5 μ L.
Mass Spectrometry Conditions in step (3): ESI+, mass spectrometry parameters: GS1 (55psi), GS2 (55psi), CURGAS (30psi), ion source temperature (550 DEG C), electron spray voltage (5500V), go bunch voltage to be 80V, collision energy is 24V.
Product of the present invention can be Chinese patent drug, health food and food.
In the inventive method, high performance liquid chromatography is by comparing chromatographic peak retention time and spectrum behavior, tentatively judges whether to detect Prozac; Liquid Chromatography/Mass Spectrometry is by comparing chromatographic peak retention time, quasi-molecular ion peak and secondary fragment information, and the structure of Prozac is confirmed, and check conclusion is accurate.The inventive method specificity is strong, and sensitivity, accuracy are high, and good stability is practical.The high performance liquid chromatography prescreening method set up has instrument price and the maintenance cost advantage more much lower than LC-MS instrument, is applicable to testing agency of basic unit and uses.Because the violation of law adding chemicals illegal in Chinese medicine, health food, food also will continue, and the development of analysis and detection technology lags behind the speed of development of adulterated false making generally, the present invention, just for the detection method that current food, drug safety supervision new situations and new problems are innovated, provides strong technical support for country formulates the illegal Prozac examination criteria that adds in product.
Accompanying drawing explanation
Fig. 1: the HPLC chromatogram of extract with fluoxetine product of the present invention; Fig. 2: the HPLC chromatogram of positive of the present invention; Fig. 3: the HPLC chromatogram of negative sample of the present invention; Fig. 4: the abosrption spectrogram of extract with fluoxetine product of the present invention; Fig. 5: the abosrption spectrogram of positive of the present invention; Fig. 6: the mass spectrogram of extract with fluoxetine product of the present invention; Fig. 7: the mass spectrogram of positive of the present invention; Fig. 8: Prozac cracking process figure.
The need testing solution of the positive in above-mentioned Fig. 2, Fig. 3, Fig. 5, Fig. 7 is the need testing solution that the sample containing Prozac is prepared according to the preparation method of need testing solution; The need testing solution of negative sample is not containing the need testing solution that the sample of Prozac is prepared according to the preparation method of need testing solution.
Embodiment
Below in conjunction with drawings and Examples, the present invention is further illustrated.
The present invention adopts: instrument and reagent: wear and pacify U3000 high performance liquid chromatograph, InertsilODS-SPC
18chromatographic column (4.6 × 150mm, 5 μm); ABSciexTripleTOF5600+ high-resolution mass spectrometer; Shimadzu NexeraUHPLCLC-30A; Chromatographic column: Shimadzu (Shim-packXR-ODS, 2.0mm × 100mm); Balance: MettlerAB135-S/FACT; Kunshan He Chuan ultrasonic instrument company limited KH-800KDE type high power numerical control Ultrasound Instrument; Reagent: methyl alcohol, acetonitrile are chromatographically pure (Merck company), it is pure that other reagent are analysis, and water is ultrapure water; Fluoxetine hydrochloride reference substance is provided by National Institute for Food and Drugs Control, lot number 100513-200401; Sample: sampling observation 74 batches, sample, comprises positive 3 batches.
One, high performance liquid chromatography primary dcreening operation and assay
The selection measuring wavelength gets extract with fluoxetine product solution in the interscan of 190nm-400nm wavelength coverage, and its maximum absorption wavelength is 226nm, therefore determines that determined wavelength is 226nm.
The selection of mobile phase has carried out the optimization of mobile phase with methanol-acetonitrile-50mmol/L potassium dihydrogen phosphate (5:30:65), methanol-acetonitrile-0.8% triethylamine solution (adjusting pH to 5.8 with phosphoric acid) (5:35:60) for mobile phase respectively, result with methanol-acetonitrile-0.8% triethylamine solution (with phosphoric acid adjust pH to 5.8) for mobile phase time, be separated better, Prozac peak shape is symmetrical.
The selection of Extraction solvent is dissolved in methyl alcohol due to Prozac, therefore selects methyl alcohol as Extraction solvent, and adopts ultrasonic process (power 800W, frequency 40kHz) 15 minutes, effectively to be extracted.
Chromatographic condition and system suitability: take octadecylsilane chemically bonded silica as filling agent; With methanol-acetonitrile-0.8% triethylamine solution (with phosphoric acid adjust pH to 5.8) (5:35:60) for mobile phase; Determined wavelength is 226nm, and scanning wavelength scope is 190 ~ 400nm; Flow velocity 1.0mL/min, sample size 5 μ L.
The preparation of reference substance solution: precision takes Fluoxetine hydrochloride reference substance and is about 100mg and puts in 100mL measuring bottle, adds methyl alcohol and makes dissolving in right amount and be diluted to scale, shake up, obtain reference substance storing solution (concentration 1.0mg/mL).Precision measures 1mL reference substance storing solution and puts in 10mL measuring bottle again, adds methanol dilution to scale, shakes up, obtain reference substance solution (concentration 0.1mg/mL).
The preparation of need testing solution: get test sample dose (solid dosage forms porphyrize, liquid dosage form direct sample), put in 50mL measuring bottle, add methyl alcohol appropriate, ultrasonic process (power 800W, frequency 40kHz) 15 minutes, let cool to room temperature, add methanol dilution to scale, shake up, filter, get filtrate as need testing solution.As need testing solution excessive concentration, exceed the typical curve range of linearity, in right amount desirable, dilute with methyl alcohol, make it in standard curve range.
Specificity is tested: result shows, positive presents the chromatographic peak identical with reference substance retention time, and negative sample is then without corresponding chromatographic peak.The absorption spectrum of chromatographic peak consistent with reference substance retention time in positive and the absorption spectrum of extract with fluoxetine product consistent.See Fig. 1 ~ 5.
Linear relationship is investigated: respectively accurate draw reference substance stock solution stepwise dilution make concentration be 0.005,0.01,0.05,0.1,0.2,0.4, the reference substance solution of 0.8mg/mL, injection liquid chromatography, record peak area.With sample introduction concentration (mg/mL) for horizontal ordinate, take peak area as ordinate, drawing standard working curve, carries out regretional analysis, and obtaining regression equation is y=145.2x+0.081, r=0.9999, and the range of linearity is 0.005mg/mL ~ 0.8mg/mL.
Accuracy (recovery) and replica test: precision takes negative sample 0.3g (being equivalent to a dose), put in 50mL volumetric flask, prepare 18 parts altogether, precision adds concentration is respectively 1.0mg/mL reference substance solution 0.25mL, 0.5mL, 2.5mL, each 6 parts of three concentration, add methyl alcohol more appropriate, recovery need testing solution is prepared by need testing solution preparation method, accurate absorption 5 μ L, measure as stated above, result average recovery rate is respectively 98.7%, 101.7%, 102.6% (three each n=6 of concentration), shows that method accuracy is high; The RSD of replica test is respectively 1.9%, 2.0%, 1.1% (three each n=6 of concentration), shows that method has good repeatability.
Stability test: get reference substance solution and need testing solution, in 0h, 1h, 2h, 4h, 8h, 24h sample introduction respectively under above-mentioned chromatographic condition, measure integrating peak areas value, the RSD of result reference substance solution and sample solution integrated value is respectively 0.40%, 0.32%, and result shows that reference substance solution and need testing solution are stable in 24h.
Detection limit is investigated: precision takes negative sample 0.3g (being equivalent to a dose), put in 50mL measuring bottle, adding concentration is 1.0mg/mL reference substance solution 0.05mL, adds methyl alcohol appropriate, ultrasonic 15 minutes, let cool to room temperature, add methanol dilution to scale, shake up, filter, get subsequent filtrate, measure, result detects and is limited to 0.17mg/g.
Two, Liquid Chromatography/Mass Spectrometry structural identification
Chromatographic condition is: with the 10mmol/L ammonium acetate solution containing 0.1% glacial acetic acid for mobile phase A, take methyl alcohol as Mobile phase B, gradient elution program 0 ~ 1min, 20%B; 1 ~ 6min, 20% ~ 80%B; 6 ~ 8min, 80%B; Determined wavelength is 226nm, flow velocity 0.3mL/min, sample size 5 μ L.
Mass Spectrometry Conditions: ESI+, mass spectrometry parameters: GS1 (55psi), GS2 (55psi), CURGAS (30psi), ion source temperature (550 DEG C), electron spray voltage (5500V), go bunch voltage to be 80V, collision energy is 24V.
The preparation precision of reference substance solution takes Fluoxetine hydrochloride reference substance in right amount, adds methyl alcohol and dissolves, make the solution of about hydrochloric Prozac 1 μ g in every 1mL.
The preparation of need testing solution: need testing solution under same, high performance liquid chromatography primary dcreening operation and assay item.As need testing solution excessive concentration, available methyl alcohol suitably dilutes.
Specificity is tested: each 5 μ L of accurate absorption reference substance solution, positive need testing solution and negative need testing solution respectively, injection liquid matter combined instrument.Result: adopt ESI positive ion scan pattern, Prozac formed quasi-molecular ion peak [M+H] peak be 310 and the stronger fragment ion peak m/e of two abundance be 44,148; In positive chromatogram, there is the corresponding chromatographic peak with extract with fluoxetine product with identical retention time and mass spectral characteristic; In negative sample chromatogram, there is not the corresponding chromatographic peak with extract with fluoxetine product with identical retention time and mass spectral characteristic.Extract with fluoxetine product mass spectrogram is shown in Fig. 6, and positive mass spectrogram is shown in Fig. 7, and Prozac cracking process is shown in Fig. 8.
Detectability gets negative sample 0.3g (being equivalent to a dose), put in 50mL measuring bottle, precision adds the Fluoxetine hydrochloride solution 0.15mL that concentration is 0.1 μ g/mL, adds methyl alcohol appropriate, ultrasonic 15 minutes, let cool to room temperature, add methanol dilution to scale, shake up, filter, get subsequent filtrate, measure, result detects and is limited to 0.05 μ g/g.
Three, the application of method
By above-mentioned condition, 74 batches of fat-reducing class Chinese patent drugs, health food and the food that market surveillance is inspected by random samples are detected, result wherein 3 batches detect Prozac, the illegal additive detected is dense (content is respectively 116.7mg/g, 110.9mg/g, 8.9mg/g), causes serious harm to the healthy meeting of consumer.
More than experiment show, the detection method that the present invention sets up can effectively screen with quantitative measurement product in illegally add Prozac, avoid vacation " positive " problem.The foundation of the method, by effectively hitting the illegal use adding Prozac in fat-reducing series products to a great extent, ensures the safety of broad masses' food and medicine.
Claims (6)
1. an illegal method of adding Prozac in testing product, is characterized in that comprising the following steps:
(1) by ultrasonic for sample methyl alcohol extraction;
(2) need testing solution after extraction is injected high performance liquid chromatograph, gradient elution is separated and diode array detector (DAD) detects, the comparing of middle chromatographic peak and extract with fluoxetine product chromatographic peak retention time and spectrum behavior per sample, preliminary screening and assay;
(3) the positive need testing solution injection liquid matter combined instrument after primary dcreening operation is carried out ultra high efficiency liquid phase gradient elution to be separated and Mass Spectrometer Method, carry out structural identification by the retention time at comparative sample peak and extract with fluoxetine product peak, quasi-molecular ion peak and second order ms patch information.
2. the method for claim 1, is characterized in that the condition of step (1) ultrasonic process is 15 minutes, power 800W, frequency 40kHz.
3. the method for claim 1, is characterized in that the chromatographic condition of step (2) is: take octadecylsilane chemically bonded silica as filling agent; With methanol-acetonitrile-0.8% triethylamine solution (with phosphoric acid adjust pH to 5.8) (5:35:60) for mobile phase; Determined wavelength is 226nm, and scanning wavelength scope is 190 ~ 400nm, flow velocity 1.0mL/min, sample size 5 μ L.
4. the method for claim 1, is characterized in that the chromatographic condition of step (3) is: with the 10mmol/L ammonium acetate solution containing 0.1% glacial acetic acid for mobile phase A, take methyl alcohol as Mobile phase B, gradient elution program 0 ~ 1min, 20%B; 1 ~ 6min, 20% ~ 80%B; 6 ~ 8min, 80%B; Determined wavelength is 226nm, flow velocity 0.3mL/min, sample size 5 μ L.
5. the method for claim 1, it is characterized in that the Mass Spectrometry Conditions in step (3): LC-MS instrument is ABSciexTripleTOF5600+ high-resolution mass spectrometer, ESI+, mass spectrometry parameters: GS1(55psi), GS2(55psi), CURGAS(30psi), ion source temperature (550 DEG C), electron spray voltage (5500V), go bunch voltage to be 80V, collision energy is 24V.
6. the method for claim 1, is characterized in that described product is Chinese patent drug, health food and food.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510784041.9A CN105403648A (en) | 2015-11-16 | 2015-11-16 | Method for detecting illegally-added fluoxetine in product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510784041.9A CN105403648A (en) | 2015-11-16 | 2015-11-16 | Method for detecting illegally-added fluoxetine in product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105403648A true CN105403648A (en) | 2016-03-16 |
Family
ID=55469264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510784041.9A Pending CN105403648A (en) | 2015-11-16 | 2015-11-16 | Method for detecting illegally-added fluoxetine in product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105403648A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110068635A (en) * | 2019-06-10 | 2019-07-30 | 无锡市药品安全检验检测中心(无锡市药品检验所) | A method of the illegal addition Fluoxetine hydrochloride of detection |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101398414A (en) * | 2008-10-15 | 2009-04-01 | 上海市公安局刑事侦查总队 | Method for qualitatively screening 242 kinds of compounds by liquid phase chromatography-mass spectra at the same times |
| CN102175778A (en) * | 2010-12-03 | 2011-09-07 | 杭州谷歌科技有限公司 | Method for synchronously measuring blood drug concentrations of multiple antidepressants |
| US20120205532A1 (en) * | 2010-08-31 | 2012-08-16 | Waters Technologies Corporation | Techniques For Sample Analysis |
| CN104535702A (en) * | 2014-12-30 | 2015-04-22 | 天津大学 | Method used for detecting multiple trace drug pollutants in drinking water simultaneously |
-
2015
- 2015-11-16 CN CN201510784041.9A patent/CN105403648A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101398414A (en) * | 2008-10-15 | 2009-04-01 | 上海市公安局刑事侦查总队 | Method for qualitatively screening 242 kinds of compounds by liquid phase chromatography-mass spectra at the same times |
| US20120205532A1 (en) * | 2010-08-31 | 2012-08-16 | Waters Technologies Corporation | Techniques For Sample Analysis |
| CN102175778A (en) * | 2010-12-03 | 2011-09-07 | 杭州谷歌科技有限公司 | Method for synchronously measuring blood drug concentrations of multiple antidepressants |
| CN104535702A (en) * | 2014-12-30 | 2015-04-22 | 天津大学 | Method used for detecting multiple trace drug pollutants in drinking water simultaneously |
Non-Patent Citations (3)
| Title |
|---|
| 张晓丹 等: "HPLC-DAD数据库快速筛查减肥类中药制剂及保健食品中的10种非法添加化学药物", 《中国新药杂志》 * |
| 王欣晨 等: "互为内标法测定患者血浆中氟西汀和西酞普兰的浓度", 《中国药师》 * |
| 车宝泉 等: "液质联用检查中药制剂及保健食品中减肥类药物", 《药物分析杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110068635A (en) * | 2019-06-10 | 2019-07-30 | 无锡市药品安全检验检测中心(无锡市药品检验所) | A method of the illegal addition Fluoxetine hydrochloride of detection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valese et al. | A fast and simple LC-ESI-MS/MS method for detecting pyrrolizidine alkaloids in honey with full validation and measurement uncertainty | |
| Aguilera-Luiz et al. | Multi-residue determination of veterinary drugs in milk by ultra-high-pressure liquid chromatography–tandem mass spectrometry | |
| Lebel et al. | A rapid, quantitative liquid chromatography-mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products | |
| Cheng et al. | Application of ultra-high-performance liquid chromatography coupled with LTQ-Orbitrap mass spectrometry for identification, confirmation and quantitation of illegal adulterated weight-loss drugs in plant dietary supplements | |
| Zhou et al. | A new approach for simultaneous screening and quantification of toxic pyrrolizidine alkaloids in some potential pyrrolizidine alkaloid-containing plants by using ultra performance liquid chromatography–tandem quadrupole mass spectrometry | |
| Zhao et al. | Simultaneous determination of ginkgo flavonoids and terpenoids in plasma: ammonium formate in LC mobile phase enhancing electrospray ionization efficiency and capacity | |
| CN104597165A (en) | Q-Orbitrap high-resolution mass spectrometric detection method for illegal additives in weight-losing type Chinese patent medicines and health foods | |
| CN105738492B (en) | The method of impurity content in LC MS/MS combination measure Lapatinibs | |
| Jeong et al. | Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography–tandem mass spectrometry | |
| CN105717237B (en) | The detection method of GABA, Glu, DA, 5-HT and Capillary zone electropheresis in a kind of serum | |
| Ullah et al. | A liquid chromatography and tandem mass spectrometry method to determine 28 non-volatile drugs of abuse in exhaled breath | |
| CN106018586A (en) | Method for simultaneously detecting seven sleep chemical medicines | |
| CN104991009A (en) | Method for determination of illegally added substances in traditional Chinese medicines and health-care products | |
| CN104237408B (en) | The detection method of compound Chlorhexidine dyclonine emulsifiable paste | |
| Heo et al. | Simultaneous analysis of cannabinoid and synthetic cannabinoids in dietary supplements using UPLC with UV and UPLC–MS-MS | |
| Lim et al. | Improvement of accuracy for the determination of vitamin A in infant formula by isotope dilution-liquid chromatography/tandem mass spectrometry | |
| Liu et al. | The simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine in rat plasma by LC-MS/MS and a pharmacokinetic comparison after the oral administration of Rhizoma coptidis and Jiao-Tai-Wan extract | |
| Liying et al. | Application of a UPLC-MS/MS method for quantitative analysis of 29 synthetic cannabinoids and their metabolites, such as ADB-BUTINACA and MDMB-4en-PINACA in human hair in real cases | |
| CN108152399B (en) | Construction and detection method of UPLC (ultra performance liquid chromatography) characteristic spectrum of semen boitae medicinal material | |
| CN113514584A (en) | Method for qualitatively and quantitatively detecting torasemide illegally added in food and application | |
| Zhang et al. | Quantification of zolmitriptan in plasma by high-performance liquid chromatography–electrospray ionization mass spectrometry | |
| CN106908532B (en) | The method for measuring aquatic products Malachite Green, quinolones, sulfa drugs | |
| Wen et al. | A sensitive liquid chromatography–electrospray ionization–mass spectrometry method for the simultaneous determination of pentoxyverine citrate and guaifenesin in human plasma—application to pharmacokinetic and bioequivalence studies | |
| Ghosh et al. | Development of stability indicating RP-HPLC method and validation for the estimation of vilazodone hydrochloride | |
| Wen et al. | Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC–MS/MS method: Application to the pharmacokinetic study in healthy Chinese volunteers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160316 |
|
| WD01 | Invention patent application deemed withdrawn after publication |